High intensity focused ultrasound, liver disease and bridging therapy

doi:10.3748/wjg.v19.i43.7494

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 43

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5544)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

366

HTML

3323

Figures (1-1)

198

Sum=3887

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

757

Download

900

Sum=1657

Nov 21, 2013 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Field Of Vision

World J Gastroenterol. Nov 21, 2013; 19(43): 7494-7499
Published online Nov 21, 2013. doi: 10.3748/wjg.v19.i43.7494

Open in New Tab Full Size Figure Download Figure

Figure 1 Approach to the management of newly diagnosed hepatocellular cancer. Source from Parikh et al[19]. “Bridging therapy”: Surgical resection, radiofrequency ablation (RFA), transcatheter arterial chemoembolization (TACE). High-intensity focused ultrasound (HIFU) as proposal. PEI: Percutaneous ethanol injection; UNOS: United network for organ sharing.

Citation: Mearini L. High intensity focused ultrasound, liver disease and bridging therapy. World J Gastroenterol 2013; 19(43): 7494-7499
URL: https://www.wjgnet.com/1007-9327/full/v19/i43/7494.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i43.7494